Patients
41.0 % of adults
Obesity (adults), US, 2024 (WHO).
Compare every country on the Public Health Dashboard
Medical Devices
US
US
US
US Body Composition Analyzers Market Industry Trends and Forecast to 2034: Segmented by (Technology, Product, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
US · 2024–2034 · estimates
Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
US (this report) at $373.8 Mn.
Canada at 8.4% a year.Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$268.5 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $351.9 Mn | — | — |
| 2025 (base) | $373.8 Mn | +$21.8 Mn | — |
| 2026 (forecast) | $396.9 Mn | +$23.2 Mn | +6.2% |
| 2027 (forecast) | $421.6 Mn | +$24.6 Mn | +12.8% |
| 2028 (forecast) | $447.7 Mn | +$26.1 Mn | +19.8% |
| 2029 (forecast) | $475.4 Mn | +$27.8 Mn | +27.2% |
| 2030 (forecast) | $504.9 Mn | +$29.5 Mn | +35.1% |
| 2031 (forecast) | $536.2 Mn | +$31.3 Mn | +43.5% |
| 2032 (forecast) | $569.5 Mn | +$33.2 Mn | +52.4% |
| 2033 (forecast) | $604.8 Mn | +$35.3 Mn | +61.8% |
| 2034 (forecast) | $642.3 Mn | +$37.5 Mn | +71.8% |
Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
US (this report)
$373.8 Mn
China
$80.2 Mn
Canada
$76.0 Mn
Japan
$72.0 Mn
Germany
$37.9 Mn
Italy
$28.6 Mn
UK
$26.2 Mn
Brazil
$26.3 Mn
France
$24.9 Mn
Ecuador
$23.4 Mn
Saudi Arabia
$20.5 Mn
India
$20.5 Mn
Spain
$18.7 Mn
Mexico
$17.4 Mn
Australia
$13.3 Mn
Russia
$11.5 Mn
New Zealand
$11.0 Mn
South Africa
$5.9 Mn
UAE
$5.2 Mn
Egypt
$2.6 Mn
Philippines
$2.4 Mn
Malaysia
$1.7 Mn
Hong Kong
$1.6 Mn
Singapore
$1.4 Mn
Thailand
$1.2 Mn
Kenya
$0.8 Mn
Body composition analyzers measure fat, muscle and water in the body, used in clinics, gyms and homes to track health and weight-loss progress.
Key segments of the body Composition Analyzers market include technology (Bioelectrical Impedance, DEXA and Air Displacement) and product (Professional Analyzers and Smart Scales).
Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the body Composition Analyzers market. Wider insurance coverage and more doctors trained in obesity care are adding to demand.
Oral formulations, combination therapies and use in heart, kidney and liver disease open new growth paths for the body Composition Analyzers market, especially in fast-growing emerging economies.
High treatment prices, limited reimbursement, supply shortages and side effects that lead some patients to stop treatment hold back the body Composition Analyzers market. Long-term safety data and lifestyle support are still needed for many patients.
The body Composition Analyzers market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how body Composition Analyzers products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in US.
What doctors and scientists are doing in Body Composition Analyzers right now, from free public sources.
41.0 % of adults
Obesity (adults), US, 2024 (WHO).
Compare every country on the Public Health DashboardSources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 11 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
OTC & Nutraceuticals · US
Pharmaceuticals · US
OTC & Nutraceuticals · US
Pharmaceuticals · US
Pharmaceuticals · US
OTC & Nutraceuticals · US